partial agonist (EC50
= 4 nM) that displays > 680-fold selectivity over 5-HT3
values are 1.07 and 730 nM respectively). Increases sAPPα
levels in the cortex in an animal model of Alzheimer's disease and exhibits progastrokinetic effects in vivo
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
New esters of 4-amino-5-chloro-2-methoxybenzoic acid as potent agonists and antagonists for 5-HT4 receptors.
Yang et al.
5-HT4 receptor agonists increase sAPPα levels in the cortex and hippocampus of male C57BL/6j mice.
Cachard-Chastel et al.
Intestinal motor stimulation by the 5-HT4 receptor agonist ML10302: differential involvement of tachykininergic pathways in the canine small bowel and colon.
Ponti et al.